ADAM three-lens brief
Evidence-based stock research on ADAM. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.20% yesterday. · Trading at 0% of its 52-week range — deep in the lower band.
- Moved -2.20% yesterday.
- Trading at 0% of its 52-week range — deep in the lower band.
- 50-day MA below 200-day MA (death-cross regime); price below both.
- RSI at 22 — technically oversold.
- Underperforming SPY by 31.1pp over 30 days.
ADAM closed at $5.33 (-2.20%) as of 2026-11-12. Market cap: $481.32M. P/E (trailing) 4.6. Price is below the 50-day MA and below the 200-day MA. Positives: p/E of 4.6 — trading at a value multiple.; analyst mean target $11.17 — 110% above current (6 analysts).. Concerns: moved -2.20% yesterday.; trading at 0% of its 52-week range — deep in the lower band.. Last quarter: Revenue $48.80M, net income -$170.98M.
Why three lenses on ADAM, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ADAM across Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://www.clearpathinvest.app/embed/ADAM" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ADAM brief"></iframe>